Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia (2008)
- Authors:
- Autor USP: SILVA, CARLOS HENRIQUE TOMICH DE PAULA DA - FCFRP
- Unidade: FCFRP
- Assunto: HIPERCOLESTEROLEMIA
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2008
- Source:
- Título: Journal of Physical Chemistry Part A
- ISSN: 1089-5639
- Volume/Número/Paginação/Ano: v. 112, n. 10, p. 2007-2011, 2008
-
ABNT
SILVA, Vinícius B. da e TAFT, Carlton A. e SILVA, Carlos Henrique Tomich de Paula da. Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia. Journal of Physical Chemistry Part A, v. 112, n. 10, p. 2007-2011, 2008Tradução . . Acesso em: 12 fev. 2026. -
APA
Silva, V. B. da, Taft, C. A., & Silva, C. H. T. de P. da. (2008). Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia. Journal of Physical Chemistry Part A, 112( 10), 2007-2011. -
NLM
Silva VB da, Taft CA, Silva CHT de P da. Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia. Journal of Physical Chemistry Part A. 2008 ; 112( 10): 2007-2011.[citado 2026 fev. 12 ] -
Vancouver
Silva VB da, Taft CA, Silva CHT de P da. Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia. Journal of Physical Chemistry Part A. 2008 ; 112( 10): 2007-2011.[citado 2026 fev. 12 ] - Planejamento racional de inibidores de enzimas-alvo aplicado a diferentes doenças: modelagem, síntese, bioquímica e QSAR
- Discovery of potential neurodegenerative inhibitors in Alzheimer’s disease by casein kinase 1 structure-based virtual screening
- Current topics in computer-aided drug design
- Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design
- General aspects of lead finding and optimization in drug discovery
- Sequence and transcriptional study of HNRPK pseudogenes, and expression and molecular modeling analysis of hnRNP K isoforms
- Molecular dynamics, density functional theory, pharmacophore modeling, molecular interaction fields and ADME/tox investigation of novel bioactive compounds interacting with CDK2 surfaces
- Pharmacophore-based drug design of novel potential tau ligands for Alzheimer's disease treatment
- RNA interference in drug discovery
- Computer-aided drug design and ADMET predictions for identification and evaluation of novel potential farnesyltransferase
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
